LUX BIOSCIENCES INC

Profile

Company Names

LUX BIOSCIENCES INC

Addresses

HARBORSIDE FINANCIAL CENTER PLAZA 10, 14TH FLOOR, JERSEY CITY, NJ 07302

Phone Numbers

2019460551

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$81,140,274.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2012-02-23 
$16,000,000.00 
$17,110,000.00 
$1,110,000.00 
Debt 
6
2011-12-05 
$4,000,000.00 
$4,350,000.00 
$350,000.00 
Debt 
5
2011-06-30 
$6,000,000.00 
$6,000,000.00 
$0.00 
Debt 
4
2011-03-03 
$3,000,000.00 
$4,500,000.00 
$1,500,000.00 
Debt 
3
2010-12-03 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
2
2009-10-15 
$37,940,274.00 
$49,940,274.00 
$12,000,000.00 
Equity 
1
2009-06-03 
$9,200,000.00 
$9,200,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDDY 
 
ANGLADE 
EXECUTIVE OFFICER
LUX BIOSCIENCES INC
A. 
CLARKE 
ATWELL 
EXECUTIVE OFFICER
LUX BIOSCIENCES INC
AXEL 
 
BOLTE 
DIRECTOR
LUX BIOSCIENCES INC   |  KOLLTAN PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  OPHTHOTECH CORP.   |  ALLENA PHARMACEUTICALS, INC.   |  NABRIVA THERAPEUTICS PLC   |  INOZYME PHARMA, INC.
PAUL 
 
CHANEY 
DIRECTOR
EYEGATE PHARMACEUTICALS INC   |  PANOPTICA, INC.   |  LUX BIOSCIENCES INC   |  ELEVEN BIOTHERAPEUTICS, INC.   |  KIORA PHARMACEUTICALS INC
PAUL 
G. 
CHANEY 
DIRECTOR
LUX BIOSCIENCES INC   |  ELEVEN BIOTHERAPEUTICS, INC.
THOMAS 
 
DYRBERG 
DIRECTOR
LUX BIOSCIENCES INC   |  GLOUCESTER PHARMACEUTICALS INC   |  OPHTHOTECH CORP.   |  ALLOCURE INC   |  PANOPTICA, INC.   |  GALERA THERAPEUTICS, INC.   |  PRAXIS PRECISION MEDICINES, INC.
GEORGE 
 
ELDRIDGE 
EXECUTIVE OFFICER
LUX BIOSCIENCES INC   |  ALLOCURE INC   |  PROTEON THERAPEUTICS INC
LUTZ 
 
GIEBEL 
DIRECTOR
LUX BIOSCIENCES INC   |  LOGICAL THERAPEUTICS INC   |  ALLOCURE INC   |  SV LIFE SCIENCES FUND V LP   |  SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.   |  PANOPTICA, INC.   |  GOOD START GENETICS, INC.   |  OPHTHOTECH CORP.   |  IPINOVYX BIO, INC.
ULRICH 
M. 
GRAU 
EXECUTIVE OFFICER, DIRECTOR
LUX BIOSCIENCES INC
DAVID 
 
GUYER 
DIRECTOR
NEOVISTA INC   |  LUX BIOSCIENCES INC   |  OPHTHOTECH CORP.   |  LINK MEDICINE CORP   |  PANOPTICA, INC.   |  ALLOCURE INC   |  SOUND PHARMACEUTICALS INC   |  INVECTYS, INC.   |  AVICEDA THERAPEUTICS, INC.   |  LIFE BIOSCIENCES LLC
DEAN 
 
MITCHELL 
EXECUTIVE OFFICER, DIRECTOR
LUX BIOSCIENCES INC   |  KINNATE BIOPHARMA INC.   |  RECODE THERAPEUTICS, INC.
DEAN 
J 
MITCHELL 
EXECUTIVE OFFICER, DIRECTOR
LUX BIOSCIENCES INC
DAVID 
 
SCHNELL 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  LUX BIOSCIENCES INC   |  NORA THERAPEUTICS, INC.   |  TRUBION PHARMACEUTICALS, INC   |  NGM BIOPHARMACEUTICALS INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SATORI PHARMACEUTICALS INC   |  ALVINE PHARMACEUTICALS INC   |  AJAX THERAPEUTICS, INC.
BRETT 
 
SKOLNIK 
EXECUTIVE OFFICER
LUX BIOSCIENCES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-23 
2011-12-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-05 
2011-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-30 
2011-03-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-03-03 
2010-12-20
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-12-03 
2009-10-30
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-10-15 
2009-06-16
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2009-06-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#